Journal article
Diagnosis of childhood febrile illness using a multi-class blood RNA molecular signature
- Abstract:
-
Background
Appropriate treatment and management of children presenting with fever depend on accurate and timely diagnosis, but current diagnostic tests lack sensitivity and specificity and are frequently too slow to inform initial treatment. As an alternative to pathogen detection, host gene expression signatures in blood have shown promise in discriminating several infectious and inflammatory diseases in a dichotomous manner. However, differential diagnosis requires simultaneous consideration of multiple diseases. Here, we show that diverse infectious and inflammatory diseases can be discriminated by the expression levels of a single panel of genes in blood.
Methods
A multi-class supervised machine-learning approach, incorporating clinical consequence of misdiagnosis as a “cost” weighting, was applied to a whole-blood transcriptomic microarray dataset, incorporating 12 publicly available datasets, including 1,212 children with 18 infectious or inflammatory diseases. The transcriptional panel identified was further validated in a new RNA sequencing dataset comprising 411 febrile children.
Findings
We identified 161 transcripts that classified patients into 18 disease categories, reflecting individual causative pathogen and specific disease, as well as reliable prediction of broad classes comprising bacterial infection, viral infection, malaria, tuberculosis, or inflammatory disease. The transcriptional panel was validated in an independent cohort and benchmarked against existing dichotomous RNA signatures.
Conclusions
Our data suggest that classification of febrile illness can be achieved with a single blood sample and opens the way for a new approach for clinical diagnosis. Funding
European Union’s Seventh Framework no. 279185; Horizon2020 no. 668303 PERFORM; Wellcome Trust (206508/Z/17/Z); Medical Research Foundation (MRF-160-0008-ELP-KAFO-C0801); NIHR Imperial BRC.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 11.0MB, Terms of use)
-
- Publisher copy:
- 10.1016/j.medj.2023.06.007
Authors
Contributors
+ Pediatric Emergency Medicine Kawasaki Disease Research Group (PEMKDRG)
- Role:
- Contributor
+ UK Kawasaki Genetics consortium
- Role:
- Contributor
+ GENDRES consortium
- Role:
- Contributor
+ EUCLIDS consortium
- Role:
- Contributor
+ PERFORM consortium
- Role:
- Contributor
- Publisher:
- Cell Press
- Journal:
- Med More from this journal
- Volume:
- 4
- Issue:
- 9
- Pages:
- P635-654.E5
- Place of publication:
- United States
- Publication date:
- 2023-08-11
- Acceptance date:
- 2023-06-19
- DOI:
- EISSN:
-
2666-6340
- ISSN:
-
2666-6359
- Pmid:
-
37597512
- Language:
-
English
- Keywords:
- Pubs id:
-
1514637
- Local pid:
-
pubs:1514637
- Deposit date:
-
2023-09-19
- ARK identifier:
Terms of use
- Copyright holder:
- Habgood-Coote et al
- Copyright date:
- 2023
- Rights statement:
- ©2023 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record